Zacks: Check Cap Ltd (NASDAQ:CHEK) Receives Consensus Rating of “Strong Buy” from Analysts
Shares of Check Cap Ltd (NASDAQ:CHEK) have been given an average broker rating score of 1.00 (Strong Buy) from the two brokers that cover the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.
Brokers have set a twelve-month consensus price target of $5.00 for the company, according to Zacks. Zacks has also given Check Cap an industry rank of 97 out of 265 based on the ratings given to related companies.
CHEK has been the topic of several research analyst reports. Maxim Group raised their price objective on Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, August 1st. Zacks Investment Research lowered Check Cap from a “buy” rating to a “hold” rating in a research note on Wednesday, July 20th.
Shares of Check Cap (NASDAQ:CHEK) opened at 1.98 on Thursday. Check Cap has a one year low of $0.97 and a one year high of $3.80. The company’s market capitalization is $24.26 million. The firm’s 50-day moving average price is $2.01 and its 200 day moving average price is $2.07.
Check Cap Company Profile
Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Check Cap Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap Ltd and related companies with MarketBeat.com's FREE daily email newsletter.